Diploma PLC (LON:DPLM - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 4,813.92 ($64.13) and traded as high as GBX 5,330 ($71.00). Diploma shares last traded at GBX 5,306.30 ($70.68), with a volume of 55,324,188 shares traded.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on the company. JPMorgan Chase & Co. reiterated a "neutral" rating and set a GBX 4,440 target price on shares of Diploma in a research report on Wednesday, August 6th. Royal Bank Of Canada upgraded Diploma to an "outperform" rating and boosted their target price for the stock from GBX 4,500 to GBX 6,000 in a research report on Friday, October 3rd. Berenberg Bank boosted their target price on Diploma from GBX 5,750 to GBX 6,350 and gave the stock a "buy" rating in a research report on Wednesday, September 10th. Shore Capital reiterated a "hold" rating and set a GBX 5,100 target price on shares of Diploma in a research report on Thursday, July 17th. Finally, Jefferies Financial Group boosted their target price on Diploma from GBX 4,500 to GBX 5,200 and gave the stock a "hold" rating in a research report on Thursday, September 11th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of GBX 5,365.
View Our Latest Report on DPLM
Diploma Trading Up 0.4%
The firm has a market cap of £7.16 billion, a price-to-earnings ratio of 4,296.06, a PEG ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The business has a fifty day moving average of GBX 5,390.71 and a two-hundred day moving average of GBX 4,813.92.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.